Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High-dose melphalan produces favorable response in a patient with multiple myeloma and coexisting essential thrombocythemia with JAK2 mutation.

× No keyword cloud information.

7 in total

1. Rare coexistence of multiple myeloma with essential thrombocythemia: report of two cases.

Authors: Navneet S Majhail; Alan E Lichtin
Journal: Haematologica Date: 2003-04 Impact factor: 9.941

2. Multiple myeloma with concomitant JAK2-positive essential thrombocythemia post-successful autologous peripheral blood hematopoietic stem cell transplant.

Authors: S G Holtan; J D Hoyer; F K Buadi
Journal: Bone Marrow Transplant Date: 2010-06-28 Impact factor: 5.483

3. Screening of JAK2 V617F mutation in multiple myeloma.

Authors: A Fiorini; G Farina; G Reddiconto; M Palladino; E Rossi; T Za; L Laurenti; S Giammarco; P Chiusolo; G Leone; S Sica
Journal: Leukemia Date: 2006-07-27 Impact factor: 11.528

4. Absence of JAK-2V617F point mutations in multiple myeloma.

Authors: Q Huang; X Li; W Chen; L M Weiss
Journal: Leukemia Date: 2007-01-18 Impact factor: 11.528

5. Essential thrombocythemia and multiple myeloma: two rare diseases in one patient.

Authors: Ahmet Emre Eskazan; Seniz Ongoren; Muhlis Cem Ar; Teoman Soysal; Burhan Ferhanoglu; Hilal Aki; Yildiz Aydin
Journal: Clin Lymphoma Myeloma Leuk Date: 2011-05-08

Review 6. The spectrum of JAK2-positive myeloproliferative neoplasms.

Authors: Jean-Jacques Kiladjian
Journal: Hematology Am Soc Hematol Educ Program Date: 2012

Review 7. Plasma cell leukemia occurring in a patient with thrombocythemia treated with hydroxyurea and busulphan.

Authors: Anna Candoni; Mario Tiribelli; Renato Fanin
Journal: Leuk Lymphoma Date: 2004-04

7 in total